The Profession
The American Society for Radiation Oncology 2017 Radiation Oncologist Workforce Study

https://doi.org/10.1016/j.ijrobp.2018.10.020Get rights and content

Purpose

The aim of this study is to report the American Society for Radiation Oncology 2017 radiation oncologist (RO) workforce survey results; identify demographic, technology utilization, and employment trends; and assess the profession's ability to meet patients' needs, offer job satisfaction, and attract high-caliber trainees.

Methods

In spring 2017, the American Society for Radiation Oncology distributed an online survey to 3856 US RO members. The questionnaire was patterned after the 2012 workforce survey for trend analysis. The 31% response rate yielded 1174 individual responses (726 practices) for analysis.

Results

ROs’ mean age was 50.9 years. Compared to 2012, female representation (28.9%) increased and white representation (69.8%) dropped. The proportion in rural practice (12.6%) decreased, whereas the number of suburban ROs (40.6%) increased and urban ROs (46.8%) remained high. Most ROs worked full-time, averaging 51.4 h/wk. Stereotactic body radiation therapy, cone beam computed tomography, and magnetic resonance/positron emission tomography-computed tomography fusion utilization increased, whereas low-dose-rate brachytherapy decreased by >15 percentage points. Hypofractionation utilization was 95.3% and was highest in academic/university systems and lowest in private solo practices (P < .001). More respondents were concerned about an RO oversupply rather than shortage. ROs reported 250 consults (median) and 20 on-treatment patients (median) in 2016 and greater time allocation to electronic health record management compared with 3 years earlier. Approximately 15% of ROs reported job vacancies, which were more prevalent in urban practices and academic/university systems. ROs were employed by academic/university systems, private practices, and nonacademic hospitals in a respective ratio of 2:2:1. Comparison with 2012 survey findings showed a shift from private practice toward academic/university systems and nonacademic hospitals. Compensation was predominantly productivity-based at private practices and a fixed salary or a base salary at academic/university systems and nonacademic hospitals. Practice merger/buyout was the lead reason for ROs to change employers.

Conclusions

Since 2012, race and gender gaps narrowed, but geographic disparities persisted, with ROs gravitating toward resource-rich suburban and urban locations over rural practices. The workforce has shifted from predominantly private practice to more equal balance with academic/university systems. These findings reflect the current US RO landscape and serve to underscore the need for collective action to ensure equitable RO care for all patients.

Introduction

The American Society for Radiation Oncology (ASTRO) has conducted several workforce studies to assess whether the US radiation oncologist (RO) profession meets patients' needs, provides a balanced workload and job satisfaction, attracts high-caliber trainees, and values diversity. These studies characterize practice structure and behaviors and help inform ASTRO positions. The first study in 1996 examined RO “manpower needs” using professional organizations’ statistics;1 the 2002 survey polled ROs on physician and nonphysician personnel staffing,2 and the 2012 study surveyed ROs and allied professionals on demographics, supply and demand, and other concerns and needs.3, 4, 5

The 2017 study results are presented here in four sections: (1) demographics, (2) technology utilization, (3) supply and demand, and (4) employment and compensation models. Where available, results from the 2012 survey are included for comparison.

Section snippets

Survey development and testing

The ASTRO Board of Directors and Workforce Subcommittee commissioned the current study in 2016. The 2012 ASTRO workforce survey was used as a basis for survey design to allow some comparison over time. The Workforce Subcommittee convened in person at the 2016 ASTRO Annual Meeting and several times remotely (via conference calls and email exchanges) thereafter to optimize the survey questionnaire. The questionnaire was pilot-tested for clarity, time to complete, and relevance. The questionnaire

Demographics

Table 1 shows demographic results. ROs’ mean age was 50.9 years (range, 24-97), slightly lower than 2012 respondents (51.4 years). More than half of the ROs (56.3%) were aged 40-59 years and nearly one-quarter (23.6%) were aged ≥60 years. Women comprised 28.9% of the workforce, up from 25.8% in 2012. The male-to-female ratio was 2.5:1 and varied by age, ranging from 2.0:1 in the <40 years group to 2.7:1 in the ≥50 group (P = .001). Ratios also varied by US region; the gap was narrowest in the

Demographics

The 2017 survey respondents are comparable to the 2012 respondents in terms of age, with roughly three-quarters of the respondents over the age of 40 years and thus in mid- to late-career. Although men outnumbered women 2.5-fold, the gender gap was narrower among the quarter of respondents aged <40 years. With over 50% female representation among medical school matriculants today,8 however, female representation in RO remains disappointingly low. Unsurprisingly, the RO profession comprises

Conclusions

Racial/ethnic minorities and women continue to be under-represented in our specialty, although the narrowing gender gap in those aged <40 years allows for some optimism. Comparison with 2012 survey results suggests ROs are gravitating to urban and suburban settings, reflecting a maldistribution that could be further exacerbated by the higher propensity of rural ROs to retire or go part-time, in addition to the skew in job vacancies toward urban settings. Survey results corroborated known

Acknowledgments

The study represents the work of the American Society for Radiation Oncology Workforce Subcommittee, chaired by Erli Chen, MS, (past) and Claire Fung, MD, (current), in collaboration with the Society of Chairs of Academic Radiation Oncology Programs, Association for Directors of Radiation Oncology Programs, and Association of Residents in Radiation Oncology. The authors thank Marina Demas for providing administrative support.

References (44)

  • S. Lutz et al.

    Palliative radiotherapy for bone metastases: An ASTRO evidence-based guideline

    Int J Radiat Oncol Biol Phys

    (2011)
  • S. Lutz et al.

    Palliative radiation therapy for bone metastases: Update of an ASTRO evidence-based guideline

    Pract Radiat Oncol

    (2017)
  • C. Hahn et al.

    Choosing wisely: The American Society for Radiation Oncology’s top 5 list

    Pract Radiat Oncol

    (2014)
  • D. Dearnaley et al.

    Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: Five-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

    Lancet Oncol

    (2016)
  • L. Incrocci et al.

    Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): Final efficacy results from a randomised, multicentre, open-label, phase 3 trial

    Lancet Oncol

    (2016)
  • S.C. Morgan et al.

    Hypofractionated radiation therapy for localized prostate cancer: An ASTRO, ASCO, and AUA evidence-based guideline

    Practical Radiation Oncology

    (2018)
  • B.P. Falit et al.

    The radiation oncology job market: The economics and policy of workforce regulation

    Int J Radiat Oncol Biol Phys

    (2016)
  • C. Shah

    Expanding the number of trainees in radiation oncology: Has the pendulum swung too far?

    Int J Radiat Oncol Biol Phys

    (2013)
  • S. Aneja et al.

    Geographic analysis of the radiation oncology workforce

    Int J Radiat Oncol Biol Phys

    (2012)
  • T.J. Royce et al.

    Training the radiation oncology workforce of the future: Course correction to supply the demand

    Int J Radiat Oncol Biol Phys

    (2017)
  • A.A. Ahmed et al.

    Close to home: Employment outcomes for recent radiation oncology graduates

    Int J Radiat Oncol Biol Phys

    (2016)
  • T.J. Royce et al.

    Radiotherapy utilization and fractionation patterns during the first course of cancer treatment in the United States from 2004 to 2014

    J Am Coll Radiol

    (2018)
  • Cited by (87)

    View all citing articles on Scopus

    Conflicts of interest: A.A., T.S., and L.G. stated they are employees of ASTRO and receive a salary.

    View full text